Literature DB >> 1245797

Direct spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias.

M B Poh-Fitzpatrick, A A Lamola.   

Abstract

Primary and secondary porphyrinemias are characterized by the presence of several porphyrin species in erythrocytes and/or plasma. Acid solvent extraction of porphyrins from natural ligands can preclude observation of significant spectral differences apparent on direct spectrofluorometric examination of porphyrin complexes in tissue. Erythrocytes and hemoglobin-free plasma obtained from 13 patients with erythropoietic, 9 with lead intoxication, 5 with porphyria cutanea tarda, 3 with iron deficiency anemia, 1 with erythropoietic porphyria, and 10 normal persons were simply diluted and analyzed spectrofluorometrically. Characteristic porphyrin-ligand spectral patterns were consistently obtained for each group of specimens, allowing diagnostic application of the data.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245797

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

1.  Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions.

Authors:  M B Poh-Fitzpatrick; A A Lamola
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

Review 2.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

3.  Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.

Authors:  Natalia Dixon; Ting Li; Brandon Marion; Denise Faust; Stephen Dozier; Anthony Molina; Sean Rudnick; Herbert L Bonkovsky
Journal:  Mol Genet Metab       Date:  2019-05-20       Impact factor: 4.797

4.  Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias.

Authors:  Eric W Gou; Manisha Balwani; D Montgomery Bissell; Joseph R Bloomer; Herbert L Bonkovsky; Robert J Desnick; Hetanshi Naik; John D Phillips; Ashwani K Singal; Bruce Wang; Sioban Keel; Karl E Anderson
Journal:  Clin Chem       Date:  2015-10-19       Impact factor: 8.327

5.  Haemoperfusion in acute intermittent porphyria.

Authors:  V Kordac; P Martásek; J Horák; M Jirsa
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

6.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.

Authors:  Norman G Egger; Douglas E Goeger; Deborah A Payne; Emil P Miskovsky; Steven A Weinman; Karl E Anderson
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

7.  Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.

Authors:  Ashwani K Singal; Csilla Kormos-Hallberg; Chul Lee; Vaithamanithi M Sadagoparamanujam; James J Grady; Daniel H Freeman; Karl E Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

8.  Fluorimetric study of the binding of protoporphyrin to haemopexin and albumin.

Authors:  A A Lamola; I Asher; U Muller-Eberhard; M Poh-Fitzpatrick
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

9.  N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: mechanism and species specificity.

Authors:  Jean-Marie Nicolas; Hugues Chanteux; Valérie Mancel; Guy-Marie Dubin; Brigitte Gerin; Ludovicus Staelens; Olympe Depelchin; Sophie Kervyn
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

10.  Activation of the complement system in patients with porphyrias after irradiation in vivo.

Authors:  H W Lim; M B Poh-Fitzpatrick; I Gigli
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.